跳至主要内容
临床试验/CTRI/2023/11/059560
CTRI/2023/11/059560尚未招募Unknown

Quality Of Life Measures after Bladder Preservation and Cystectomy: A prospectivelongitudinal comparative study - QOMPACT

Tata Memorial Centre Department of Atomic Energy Clinical Trial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age above 18 years
  • 2.Able to understand and sign the informed consent form in English, Hindi, or Marathi.
  • 3.Able to understand and fill the QOL questionnaires in English, Hindi, or Marathi.
  • 4.Patients with pathologically confirmed bladder cancer planned for curative intent treatment at TMC Mumbai.
  • 5.AJCC Clinical Stage T1-T4, N0-N3, M0
  • 6.Planned for treatment with either radical cystectomy with ileal conduit (RCIC) or radiotherapy with or without chemotherapy as a part of bladder preservation approach.
  • 7.May or may not have received neoadjuvant chemotherapy with either approach

排除标准

  • 1.Patients with a history of prior radiation to the pelvis
  • 2.Patients in whom the cystectomy is planned as a salvage procedure
  • 3.Patients who are planned for a neobladder after cystectomy
  • 4.Patients who have any other active malignancy
  • 5.Patients who are being considered for palliative or weekly radiotherapy
  • 6.Patients who refuse to consent to the study

研究者

发起方
Tata Memorial Centre Department of Atomic Energy Clinical Trial Centre

相似试验